DouglasStewartLevineMD

PubMed

• 14 citations
  Symptom response and healing of erosive esophagitis with proton-pump inhibitors in patients with Helicobacter pylori infection.
  Nimish Vakil, Barry Traxler, Douglas S. Levine
  The American Journal of Gastroenterology. 2004-08-01
• 67 citations
  MANAGEMENT OF DYSPLASIA IN THE COLUMNAR-LINED ESOPHAGUS
  Douglas S. Levine
  Gastroenterology Clinics of North America. 1997-09-01
• 25 citations
  Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis.
  T A Brentnall, R C Haggitt, P S Rabinovitch, M B Kimmey, M P Bronner
  Gastroenterology. 1996-02-01

Journal Articles

• A model of healing of Los Angeles grade C and D reflux esophagitis: is there an optimized time of acid suppression for maximal healing.  
  Katz PO, Johnson DA, Levine D, Rohss K, Junghard O, Astrand M, Nagy P, Aliment Pharmacol Ther 2010; 32:443-447
• Barrett’s esophagus.  
  Levine DS, Sci Am Sci Med 1994; 1(5):16-25
• Barrett’s esophagus: Pathophysiology and cancer risk Practical.  
  Reid BJ, Levine DS, Gastroenterol 1994;18:S20-S23
• Commentary: Barrett’s oesophagus and p53.  
  Levine DS, The Lancet 1994;344:212-213
• Barrett’s esophagus: The biology of neoplastic progression.  
  Neshat K, Sanchez CA, Galipeau PC, Levine DS, Reid BJ, Gastroenterol Clin Biol 1994;18:D71-D76
• Immune modulating therapies for idiopathic inflammatory bowel diseases.  
  Levine DS, Adv Pharmacol 1994;25:171-234
• Pericholangitis in patients with ulcerative colitis and risk factors for progression to colorectal cancer.  
  Levine DS, Am J Gastroenterol 1993;88:1151-1154
• Immunoglobulin therapy in idiopathic inflammatory bowel disease.  
  Levine DS, Can J Gastroenterol 1993;7:187-195
• Colonic and anorectal disorders: Diagnosis and treatment.  
  Levine DS, Geriatrics 1992;47:22-36
• Endoscopic diagnosis of esophageal neoplasms.  
  Levine DS, Reid BJ, Gastrointest Endosc Clin No Am 1992;2:395-413
• Normal histology of the colon.  
  Levine DS, Haggitt RC, Am J Surg Pathol 1989;13:966-984
• Esomeprazole formulary exclusion: impact on health care use and costs.  
  Alemayehu B, Ke X, Youssef NN, Crawley JA, Levine DS, Postgrad Med 2012:124:149-163
• Barrett’s esophagus: A model of human neoplastic progression.  
  Neshat K, Sanchez CA, Galipeau PC, Cowan DS, Ramel S, Levine DS, Reid BJ, CSH Symp Quant Biol 1994;59:577-583
• Prevention of relapse of healed reflux esophagitis is related to the duration of intragastric pH>4.  
  Johnson DA, Katz PO, Levine D, Röhss K, Åstrand M, Junghard O, Nagy P, J Clin Gastroenterol 2010;44:475-478
• Effects of esomeprazole combined with aspirin or rofecoxib on prostaglandin E2 production in patients with Barrett’s esophagus.  
  Triadafilopoulos G, Kaur B, Sood S, Traxler B, Levine D, Weston A, Aliment Pharmacol Ther 2006; 23:997-1005
• Esomeprazole resolves chronic heartburn in patients without erosive oesophagitis.  
  Katz PO, Castell DO, Levine DS, Aliment Pharmacol Ther 2003; 18:875-882
• A randomized, double blind, dose-response comparison of balsalazide (6.75 g), balsalazide (2.25 g), and mesalamine (2.4 g) in the treatment of active, mild-to-moderate...  
  Levine DS. Riff DS. Pruitt R. Wruble L. Koval G. Sales D. Bell JK. Johnson LK, Am J Gastroenterol 2002; 97:1398-1407
• Nonsteroidal anti-inflammatory drug use, body mass index, and anthropometry in relation to genetic and flow cytometric abnormalities in Barrett's esophagus.  
  Vaughan TL. Kristal AR. Blount PL. Levine DS. Galipeau PC. Prevo LJ. Sanchez CA. Rabinovitch PS. Reid BJ, Cancer Epidemiol Biomarkers Prev 2002;11:745-52
• Predictors of progression in Barrett’s esophagus III: Baseline flow cytometric variables.  
  Rabinovitch PS, Longton G, Blount PL, Levine DS, Reid BJ, Am J Gastroenterol 2001; 96:3071-3083
• Predictors of progression in Barrett’s esophagus II: 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression.  
  Reid BJ, Prevo LJ, Galipeau PC, Sanchez CA, Longton G, Levine DS, Blount PL, Rabinovitch PS, Am J Gastroenterol 2001;96:2839-2848
• Omeprazole use and administration techniques in pediatrics: A review.  
  Zimmerman TE, Katona BG, Souney PF, Levine DS, Clin Therapeutics 2001;23:660-679
• Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn’s disease.  
  Fedorak RN, Gangl A, Elson CO, Rutgeerts P, Schreiber S, Wild G, Hanauer SB, Kilian A, Cohard M, LeBeaut A, Feagan, The Interleukin 10 Inflammatory Bowel Disease Coope..., Gastroenterology 2000;119:1473-1482
• Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn’s disease.  
  Schreiber, S, Fedorak RN, Nielsen OH, Wild G, Williams CN, Nikolaus S, Jacyna M, Lashner BA, Langl A, Rutgeerts P, Isaacs K, Van Deventer SJH, Koningsberger JC, Cohard..., Gastroenterology 2000;119:1461-1472
• Optimizing endoscopic biopsy detection of early cancers in Barrett’s high-grade dysplasia.  
  Reid BJ, Blount PL, Feng Z, Levine DS, Am J Gastroenterol 2000;95:3089-3096
• Long-term management of GERD and its complications - panel discussion.  
  Boyce HW, Richter JE, Freston JW, Levine DS, Lechago J, Kahrilas PJ, Am J Gastroenterol 1997;92(suppl):S34-S35
• Join now to see all

Books/Book Chapters

• Accomplishments in oncology: Premalignant lesions of the esophagus and colon. 
  Chapter: Ultrastructural insights into Barrett’s esophagus: Comparative electron microscopic studies 
  Page 45 - 65Levine DSEditors: Hirschowitz BI.Lippincott, PhiladelphiaEdition 3,
• Proceedings of the International Society for Optical Engineering: New technologies in cytometry. 
  Chapter: Flow cytometric changes that precede cancer: Premalignant gastrointestinal disease 
  Page 170 - 177Rabinovitch PS, Burmer GB, Haggitt RC, Levine DS, Rubin CE, Reid BJEditors: Salzman GC.The Society of Photo-Optical Instrumentation Engineers - the International Society for Optical..., Bellingham, WashingtonEdition 1063,
• Dysplasia and cancer in colitis. 
  Chapter: Flow cytometry: Overview and changes in ulcerative colitis 
  Page 209 - 217Levine DSEditors: Riddell RH.Elsevier, New York
• Immunotherapy with intravenous immunoglobulins. 
  Chapter: Intravenous immunoglobulin in idiopathic inflammatory bowel disease: Results of an open-label therapeutic trial 
  Page 359 - 376Ochs HD, Fischer SH, Christie DL, Haggitt RC, Levine DSEditors: Imbach P.Academic Press, London
• Histology for pathologists. 
  Chapter: Colon 
  Page 573 - 591Levine DS, Haggitt RCEditors: Sternberg SS.Raven Press, New York
• Textbook of gastroenterology. 
  Chapter: Endoscopic mucosal biopsy 
  Page 2479 - 2523Rubin CE, Haggitt RC, Levine DSEditors: Yamada T, Alpers HD, Owyang C, Powell DW, Silverstein FE.Lippincott, Philadelphia
• Inflammatory bowel disease: From bench to bedside. 
  Chapter: Clinical features and complications of Crohn’s disease 
  Page 296 - 316Levine DSEditors: Targan SR, Shanahan F.Williams & Wilkins, Baltimore
• Allergy, asthma, and immunology from infancy to adulthood. 
  Chapter: Inflammatory bowel diseases 
  Page 687 - 702Levine DSEditors: Bierman CW, Pearlman DS, Shapiro GG, Busse WW.W.B. Saunders Company, PhiladelphiaEdition 3,
• Conn’s current therapy. 
  Chapter: Ulcerative colitis 
  Page 468 - 473Levine DSEditors: Rakel RE.Saunders, Philadelphia
• Gastroenterology updates. 
  Chapter: Barrett’s esophagus 
  Page 1 - 18Levine DSEditors: Yamada T, Alpers DH, Laine L, Owyang C, Powell DW.Lippincott-Raven, PhiladelphiaEdition 2,
• Intravenous immunoglobulins in clinical practice. 
  Chapter: Intravenous immunoglobulin therapy in idiopathic inflammatory bowel diseases 
  Page 451 - 465Levine DSEditors: Lee ML, Strand V.Marcell Dekker, New York
• Histology for pathologists. 
  Chapter: Colon 
  Page 519 - 537Levine DS, Haggitt RCEditors: Sternberg SS.Lippincott-Raven, PhiladelphiaEdition 2,
• Atlas of gastrointestinal endoscopy. 
  Silverstein FE, Tytgat GNJGower, New YorkEdition 2,
• Atlas of gastrointestinal endoscopy. 
  Silverstein FE, Tytgat GNJMosby-Wolf, LondonEdition 3,
• Join now to see all

Abstracts/Posters

• A saffron collagen stain facilitates the diagnosis of solitary ulcer-colitis cystica profunda in the usual shallow rectal biopsy.
  Levine DS, Surawicz CM, Ajer TN, Rubin CE, Gastroenterology 1985;88:1473
• Endoscopic-fluoroscopic intubation of the small bowel in a patient with oculodentodigital dysplasia (ODDD).
  Levine DS, Rohrmann CA, Silverstein FE, Gastrointest Endosc 1985;31:132-133
• Cimetidine mucosal protection: A dose response study.
  Silverstein FE, Saunder DR, Chapman RW, Levine DS, Kimmey MB, Reid BJ, Gastrointest Endosc 1985;31:136
• Differentiation of idiopathic inflammatory bowel disease from solitary rectal ulcer-colitis cystica profunda syndrome by demonstration of excess rectal mucosal collagen.
  Levine DS, Surawicz CM, Ajer TN, Rubin CE, Proceedings of the Second International Symposium on Inflammatory Bowel Disease, Jerusalem, Israel
• Demonstration of mucosal fibrosis differentiates solitary rectal ulcer syndrome from idiopathic inflammatory bowel disease.
  Levine DS, Surawicz CM, Ajer TN, Rubin CE, Clin Res 1986;34:30A
• Electron microscopic evidence for the gastric origin of Barrett’s metaplasia and dysplasia.
  Levine DS, Rubin CE, Gastroenterology 1986;90:1519
• Neoplastic features of dysplastic epithelium in Barrett’s esophagus by electron microscopy.
  Levine DS, Rubin CE, Gastroenterology 1986;90:1519
• Selective delivery of orally administered beclomethasone dipropionate (BDP) to the terminal ileum and right colon.
  Levine DS, Ainardi V, Raisys VA, Rubin CE, Gastroenterology 1986;90:1519
• Mucosal protection with misoprostol: Dose response study using a single dose aspirin model.
  Silverstein FE, Kimmey MB, Saunders DR, Levine DS, Gastrointest Endosc 1986;32:176-177
• Barrett’s esophagus: Ultrastructural epithelial abnormalities in dysplasia and adenocarcinoma.
  DS, Reid BJ, Rubin CE, Haggitt RC, Gastroenterology 1987;92:1503
• Provision of iron-containing diet does not induce expression of transferrin and transferrin receptors in mouse enterocyte microvillous brush border membrane.
  Levine DS, Woods JW, Gastroenterology 1987;92:1504
• Electron microscopic comparison of human jejunum and ileum: Fasting and during fat abosorption.
  Levine DS, Surawicz CM, Saunders DR, Rubin CE, Gastroenterology 1987;92:1504
• EM of Barrett’s esophagus: Dysplasia and early carcinoma have aberrations of mucus synthesis that correlate with aneuploidy or increased G2/tetraploid fractions.
  Levine DS, Reid BJ, Haggitt RC, Rubin CE, Rabinovitch PS, J Cell Biol 1987;105:78a
• Solitary rectal ulcer syndrome: Are solitary rectal ulcer syndrome and “localized colitis cystica profunda” analogous syndromes caused by rectal prolapse.
  Levine DS, Gastroenterol Digest 1987;3:3-4
• Parenteral desferrioxamine blocks mucosal iron absorption in rodent and man.
  Levine DS, Huebers HA, Rubin CE, Finch CA, Gastroenterology 1988;94:A259
• Distribution of aneuploidy and proliferative abnormalities in sporadic colon cancers and morphologically normal surrounding mucosa.
  Levine DS, Reid BJ, Haggitt RC, Rubin CE, Dean PJ, Rabinovitch PS, Gastroenterology 1988;94:A259
• Frequency and distribution of aneuploid cell populations in chronic ulcerative colitis.
  Levine DS, Reid BJ, Haggitt RC, Rubin CE, Dean PJ, Rabinovitch PS, Gastroenterology 1988;94:A260
• Effects of cimetidine (Cim) and methscopolamine (MS) on stimulated acid secretion and esophageal acid exposure in patients with Barrett’s esophagus.
  Mulholland MW, Melendez RL, Reid BJ, Levine DS, Rubin CE, Gastroenterology 1988;94:A314
• Stimulated gastric acid secretion in patients with reflux esophagitis.
  Mulholland MW, Melendez RL, Reid BJ, Levine DS, Rubin CE, Gastroenterology 1988;94:A314
• Correlation of ultrastructural aberrations with dysplasia and flow cytometric abnormalities in Barrett’s epithelium.
  Levine DS, Gastroenterol Digest 1989;8:17-18
• Proliferative abnormalities and histologic indicators of neoplastic risk in Barrett’s esophagus.
  Reid BJ, Pope EW, Levine DS, Haggitt RC, Dean PJ, Blount PL, Rabinovitch PS, Gastroenterology 1990;98:A111
• Aneuploidy in ulcerative colitis biopsies that are histologically indefinite for dysplasia may predict future progression to definite dysplasia.
  Haggitt RC, Rubin CE, Levine DS, Dean PJ, Rabinovitch PS, Gastroenterology 1990;98:A173
• Immunoglobulin therapy for active and extensive idiopathic ulcerative colitis and Crohn’s colitis.
  Fischer SH, Levine DS, Haggitt RC, Christie DL, Ochs HD, Gastroenterology 1990;98:A170
• Deregulation of centriole number accompanies formation of a tetraploid intermediate during neoplastic progression in a transgenic mouse model of pancreatic cancer.
  Levine DS, Sanchez CA, Rabinovitch PS, Reid BJ, Gastroenterology 1990;98:A225
• Flow cytometrically identified fields of abnormal proliferation surround some but not all colonic neoplasms.
  Levine DS, Reid BJ, Haggitt RC, Rubin CE, Dean PJ, Silverman BA, Rabinovitch PS, Gastroenterology 1990;98:A294
• Join now to see all